Medical management of symptomatic severe aortic stenosis in patients non-eligible for transcatheter aortic valve implantation  

作　　者：Gabriela Silvia Gheorghe Andreea Simona Hodorogea Andrei Cristian Dan Gheorghe Ioan Tiberiu Nanea Ana Ciobanu 

机构地区：[1]University of Medicine and Pharmacy Carol Davila,Bucharest,Prof.Dr.Th.Burghele Hospital,Bucharest,Romania

出　　处：《Journal of Geriatric Cardiology》2020年第11期704-709,共6页老年心脏病学杂志（英文版）

摘　　要：1 Transcatheter aortic valve implantation in symptomatic severe aortic stenosis: where do we stand? Aortic stenosis occurs in 2%-9% of patients over the age of 65, the most common cause being degenerative.^([1,2]) The preferred treatment in symptomatic severe aortic stenosis(SAS) is surgical aortic valve replacement(SAVR), but in the elderly, the surgical risk can be greater than the benefit.([3]).

关 键 词：Angiotensin-converting enzyme inhibitors BETA-BLOCKERS Calcium channel blockers DIURETICS Symptomatic severe aortic stenosis Transcatheter aortic valve implantation 

分 类 号：R654.2[医药卫生—外科学]